他克莫司治疗难治性肾病综合征1例

下载PDF

导出

摘要他克莫司（tacrolimus,TAC）是一种新型强效的免疫抑制药,但其确切的分子作用机制仍不清楚。目前TAC应用于防治肝脏或肾脏移植术后移植物的排斥反应,后来发现TAC治疗狼疮性肾炎有较好的疗效.

作者关欣郑红光

机构地区沈阳军区总医院肾脏内科

出处《医药导报》 CAS 2011年第2期219-220,共2页 Herald of Medicine

关键词他克莫司肾病综合征

参考文献5

1CHOUDHRY S,BAGGA A,HARI P,et al.Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome:a randomized controlled trial[J].Am J Kidney Dis,2009,53(5):760-769.
2BUTANI L,RAINSAMOOJ R.Experience with tacrolimus in children with steroid-resistant nephrotic syndrome[J].Pediatr Nephrol,2009,4(8):1517-1523.
3夏东亚,史国兵,蒋苓.6062例次他克莫司全血浓度监测结果分析[J].医药导报,2008,27(8):999-1001. 被引量：10
4WESTHOF T H,VANDER G M.Tacrolimus in the treatment of idiopathic nephrotic syndrome[J].Expert Opin Investig Drugs,2007,16(7):1099-1110.
5MIAO L,SUN J,YUAN H,et al.Combined therapy of low-dose tacrolimus and prednisone in nephrotic syndrome with slight mesangial proliferation[J].Nephrology Arlton,2006,11(5):449-454.

1KINO T, HATANAKA H, HAHIMOTO M, et al. FK506, a novel immunosuppressant isolated from a streptomyces. L Fermentation, isolation, and physio-chemical and biological characteristics [J]. J Antibiotics, 1987, 40: 1249- 1255.
2WALLEMACQ P E, REDING R. FK506(tacrolimus) , a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects[J]. Clin Chem, 1993, 39:2219 -2228.
3VENKATARAMANAN R, SWAMINATHAN A, PRASAD T, et al. Clinical pharmacokinctics of tacrolimus[J]. Clin Pharmacokinet, 1995, 29:404-430.
4USKO W J, THOMSON A W, FUNG J J, et al. Consensus document : therapeutic monitoring of tacrolimus (FKS06) [J]. Ther Drug Monit, 1995, 17:606-614.
5MACFARLANE G, SCHELLER D, ERSFELD D, et al. A simplified whold blood enzyme-linked immunosorbent assay (ProTrac Ⅱ) for tacrolimus (FK506) using proteolytic extraction in place of organic solvents [ J ]. Ther Drug Monit, 1996,18:698 - 705.
6TAYLOR P J, JONES A, BALDERSON G A, et al. Sensitive, specific quantitative analysis of tacrolimus ( FK506 ) in blood by liquid chromatography electrospray tandem mass spectrometry [ J ]. Clin Chem, 1996,42:279 - 285.
7GARG U C, AUSTIN G, BARNES C,et al. Comparison of the abbott imx tacrolimus Ⅰ and tacrolimus Ⅱ assays[ J]. Clin Chem, 1998, 44: 1783 - 1785.
8MACFARLANE G D, SCHELLER D G, ERSFELD D L, et al. Analytical validation of the PRO-Trac Ⅱ ELISA for the determination of tacrolimus( FK506 ) in whole blood [ J]. Clin Chem, 1999, 45 ( 9 ) : 1449 - 1458.

1孙玉红,汪晓娟,戎成婷,罗晶晶,吴新安.他克莫司致药物不良反应发生影响因素分析及风险预测列线图模型构建[J].临床军医杂志,2022,50(9):938-941. 被引量：2
2张弋,沈中阳.调整给药方案对他克莫司低谷浓度肝移植患者的影响[J].中国药房,2010,21(46):4357-4358. 被引量：2
3许桐林,蔡卫华,胡进勇,卢朝德,肖旭,邱烽.肝移植术后患者他克莫司血药浓度的比较[J].齐齐哈尔医学院学报,2011,32(11):1772-1773. 被引量：3
4吴健.他克莫司过量导致肾移植术后严重不良反应1例[J].中国现代医生,2012,50(10):124-124.
5曹伟,王祥慧,徐达,周佩军,何乐.临床药师参与肾移植后肺部感染患者的药物治疗实践[J].中国临床药学杂志,2013,22(6):369-372. 被引量：2
6李想,颜鸣,史国兵,夏东亚,任天舒.两种免疫法联合肾功能指标测定他克莫司血药浓度的比较[J].中国组织工程研究,2014,18(5):736-741. 被引量：5
7孙雨平,史国兵,樊蓉,李想,宋娟.他克莫司致不良反应67例文献分析[J].医药导报,2014,33(11):1535-1537. 被引量：25
8王静,韩锐,白菁安,史忠梅,刘疆,张丽娟,陈彩凤,王文波.他克莫司致血栓性静脉炎1例[J].中国药师,2016,19(7):1346-1347. 被引量：3
9蒋艳,邹素兰,陈荣,吴萍,许贤林,姜庆波.他克莫司血药浓度与胱抑素C在肾移植受者中的相关性分析[J].中国药师,2017,20(3):488-490. 被引量：4

医药导报

2011年第2期

内容加载中请稍等...